about
Emerging and Evolving Ovarian Cancer Animal ModelsProtective Effect of Progesterone during Pregnancy against Ovarian Cancer.Expression patterns of Thymosin β4 and cancer stem cell marker CD133 in ovarian cancers.The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cellsHormonal risk factors for ovarian cancer in the Albanian case-control studyEpithelial ovarian carcinoma types and the coexistence of ovarian tumor conditions.The role of the REG4 gene and its encoding product in ovarian epithelial carcinomaAutoantibodies to mesothelin in infertility.Epithelial ovarian tumors: Clinicopathological correlation and immunohistochemical study.Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.The role of infectious agents in urogenital cancersBTG1 expression correlates with the pathogenesis and progression of ovarian carcinomasHuman papillomavirus genotyping and integration in ovarian cancer Saudi patients.Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation.The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.The role of EMMPRIN expression in ovarian epithelial carcinomas.Suppression of GNAI2 message in ovarian cancer.Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.Ovarian tissue characterization in ultrasound: a review.Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.Epigenetic biomarkers in the diagnosis of ovarian cancer.B-cell translocation gene 1 is downregulated by promoter methylation in ovarian carcinoma.Comparison between multi-slice spiral CT and magnetic resonance imaging in the diagnosis of peritoneal metastasis in primary ovarian carcinoma.Primary adenocarcinoma of the fallopian tube presenting as hydrosalpinx
P2860
Q26783909-96F3776A-5F07-4A1A-BF88-E4FCD09DA9B5Q34305384-D5355F96-8EC6-4230-B7B7-4F9618DF3A56Q34440409-453161A4-93FF-449A-9857-AC3983240A6BQ35043888-10522DA8-2972-43BC-A8BA-DF16A51A2AFFQ35099774-495394EA-13BE-459B-B566-FB7253DD6641Q35116928-C8243F6E-0C18-4823-B9A8-82E10E465FEBQ35664633-2270FAF9-2D85-4FAF-BFCA-28F18B7499BDQ35832948-D7A167BD-13CB-4647-A17C-BF9B463ECDD4Q36550000-AE49AA28-E468-4E0E-8B2D-DFE2CC59E70FQ36729132-07471718-33BB-4269-914A-9F5CDC7764C6Q36767079-15A5B448-73AB-4245-8B9F-59ED220BFE76Q37291160-37594F49-C55A-4EA0-8FFC-F19830008533Q37348056-AEB6EECD-A00C-4DB3-A64D-4470A3FDD607Q37414190-D4D2AB1C-C32C-43C5-9D81-E4BB584C1BA7Q37420970-1055A33E-06FF-4F1E-85D2-209A5789CC2AQ37505550-222F47F8-F032-49E9-81AF-16D4DC166675Q37526611-F2F65B40-8BB1-4A7C-8EBF-155477BF3A64Q38244309-4E430915-D484-40E0-9110-E1E31AE1C43CQ38250447-7CCDAA4B-040D-4893-8021-8EE3360AE337Q39077657-1F6B2C2D-861F-4D6E-8A8F-6AEEB080AB79Q39453522-F502AC8F-B7CE-4631-857A-62DC2D6F1D34Q41721841-CC139665-4925-4411-8668-ACBD813DE86EQ52657240-014FD23B-2584-41FA-8990-3E77F4EEF0C0Q57601784-C04B25C5-7791-4920-9CF5-9B2A5E300AB9
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Ovarian carcinogenesis: an alternative hypothesis.
@ast
Ovarian carcinogenesis: an alternative hypothesis.
@en
Ovarian carcinogenesis: an alternative hypothesis.
@nl
type
label
Ovarian carcinogenesis: an alternative hypothesis.
@ast
Ovarian carcinogenesis: an alternative hypothesis.
@en
Ovarian carcinogenesis: an alternative hypothesis.
@nl
prefLabel
Ovarian carcinogenesis: an alternative hypothesis.
@ast
Ovarian carcinogenesis: an alternative hypothesis.
@en
Ovarian carcinogenesis: an alternative hypothesis.
@nl
P1476
Ovarian carcinogenesis: an alternative hypothesis
@en
P2093
Paul J van Diest
René H M Verheijen
P356
10.1007/978-0-387-68969-2_7
P407
P50
P577
2008-01-01T00:00:00Z